Prevention of Seasonal Affective Disorder

• Status: Completed
• Trial end date: 2003-06-01
• Target enrollment: 0
• Participant gender: All

Summary

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)

• Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)

• Patient has a current or past history of seizure disorder or brain injury.

• Patient has a history or current diagnosis of anorexia nervousa or bulimia.

• Patient has recurrent summer depression more frequently than winter depression.

• Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.

• Patient has initiated psychotherapy within the last 3 months.